Statistics

Views

Abstract: 2532

PDF (English): 672

Cited-by

CrossRef: 40

  1. Ahmad S. Meet the Executive Guest Editor. Mini-Reviews in Medicinal Chemistry. 2024;24(14):1307. doi: 10.2174/138955752413240422155139
  2. Yadav P, Tripathi MK, Yadav MK. Structure‐Guided Identification of Novel Aromatase Inhibitors Targeting Breast Carcinoma. Chemistry & Biodiversity. 2024;21(11). doi: 10.1002/cbdv.202401465
  3. Shah AA, Kumar N, Bedi P, Akhtar S. Molecular modeling, dynamic simulation, and metabolic reactivity studies of quinazoline derivatives to investigate their anti-angiogenic potential by targeting wild EGFR wt and mutant EGFR T790M receptor tyrosine kinases . Journal of Biomolecular Structure and Dynamics. 2024;42(23):13130. doi: 10.1080/07391102.2023.2274974
  4. Aloqbi AA, Alahdal H, Alqosaibi AI, Alnamshan MM, Al-Dhuayan IS, Al-Eidan AA, et al. Lucidin from Rubia cordifolia Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins. Pharmaceuticals. 2025;18(1):68. doi: 10.3390/ph18010068
  5. Hakami MA. Harnessing machine learning potential for personalised drug design and overcoming drug resistance. Journal of Drug Targeting. 2024;32(8):918. doi: 10.1080/1061186X.2024.2365934
  6. Alzain AA, Elbadwi FA, Mukhtar RM, Shoaib TH, Abdelmoniem N, Miski SF, et al. Design of new Mcl-1 inhibitors for cancer using fragments hybridization, molecular docking, and molecular dynamics studies. Journal of Biomolecular Structure and Dynamics. 2025;43(1):386. doi: 10.1080/07391102.2023.2281637
  7. Alshehri MA, Alahdal H, Aloqbi AA, Shakoori AM, Sindi G, Bagadood RM, et al. Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer. Frontiers in Oncology. 2025;15. doi: 10.3389/fonc.2025.1598883
  8. Helmi N, Hamadi A, Al-Amer OM, Madkhali HA, Oyouni A, Alqosaibi AI, et al. Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins. Medical Oncology. 2024;41(9). doi: 10.1007/s12032-024-02462-x
  9. Sharmah H, Patowary P, Ahmed LA, Deka B, Mustaque AS, Sahariah BJ. Coumarin-indole hybrids: synthesis, characterization & anti-inflammatory evaluation. Journal of the Indian Chemical Society. 2025;102(10):102018. doi: 10.1016/j.jics.2025.102018
  10. Almufarriji FM, Alotaibi BS, Alamri AS, Alkhorayef N, Alnomasy SF, Alqahtani M, et al. Probing the multitargeted potency of FDA-approved Amifostine against MRSA and control comparison with sulfamethoxazole to establish alternative medications. Microbial Pathogenesis. 2025;203:107485. doi: 10.1016/j.micpath.2025.107485
  11. Alghamdi YS, Mashraqi MM, Alsalmi O, Alharthi AA, Gharib AF. Multitargeted Docking, DFT-Based Optimisation, Pharmacokinetics, and MD Simulation Reveal 6-Oxidopamine HBr as a Multitargeted Inhibitor of Cervical Cancer Proteins. Current Medicinal Chemistry. 2025;32(17):3493. doi: 10.2174/0109298673289824240529063416
  12. Zhao D, Mo Y, Neganova ME, Aleksandrova Y, Tse E, Chubarev VN, et al. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers. Frontiers in Cell and Developmental Biology. 2023;11. doi: 10.3389/fcell.2023.1266537
  13. Murad H, Rafeeq M. Cheminformatics approach for identification of N-HyMenatPimeMelly as a novel potential ligand against RAS and renal chloride channel . Journal of Biomolecular Structure and Dynamics. 2024;42(23):12836. doi: 10.1080/07391102.2023.2273439
  14. Hakami MA, Hazazi A, Albloui F, Gharib AF, Alsaeedi FA, Abdulaziz O, et al. Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations. International Journal of Molecular Sciences. 2024;25(1):592. doi: 10.3390/ijms25010592
  15. Ahmad S, Raza K. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study. Molecular Diversity. 2024;28(3):1189. doi: 10.1007/s11030-023-10648-0
  16. Thrilokraj R, Khavatakoppa D, Hegde RV, Małecki JG, Limaye AS, Kshirsagar UA, et al. An expedient access to aminoquinazolines and quinazolinones via N-atom insertion reaction using copper nano particles decorated on magnetic carbon spheres. Materials Today Chemistry. 2024;42:102395. doi: 10.1016/j.mtchem.2024.102395
  17. Almasoudi HH, Hakami MA, Alhazmi AY, Makkawi M, Alasmari S, Alghamdi YS, et al. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study. Medical Oncology. 2023;40(8). doi: 10.1007/s12032-023-02094-7
  18. Shafiq N, Arshad M, Ali A, Rida F, Mohany M, Arshad U, et al. Integrated computational modeling and in-silico validation of flavonoids-Alliuocide G and Alliuocide A as therapeutic agents for their multi-target potential: Combination of molecular docking, MM-GBSA, ADMET and DFT analysis. South African Journal of Botany. 2024;169:276. doi: 10.1016/j.sajb.2024.04.031
  19. Binshaya AS, Alkahtani OS, Aldakheel FM, Hjazi A, Almasoudi HH. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Medical Oncology. 2024;41(5). doi: 10.1007/s12032-024-02342-4
  20. Liu C, Wang Q, Lei Y, El-Aty A, Zhang G. Identification of Flavonoid from Wolfberry (Lycium barbarum) by Using Two-Step Chromatography and Bioactivity Exploration. Food Analytical Methods. 2024;17(11):1550. doi: 10.1007/s12161-024-02672-z
  21. Almasoudi HH, Nahari MH. Targeting Plasmodium falciparum Schizont Egress Antigen-1 in Infected Red Blood Cells: Docking-Based Fingerprinting, Density Functional Theory, Molecular Dynamics Simulations, and Binding Free Energy Analysis. Pharmaceuticals. 2025;18(2):237. doi: 10.3390/ph18020237
  22. Ahmad S, Raza K. An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives. Journal of Drug Targeting. 2024;32(6):635. doi: 10.1080/1061186X.2024.2347358
  23. Kumar A. ZINC1797251, a novel natural product small molecule targets viral oncoprotein E6 in human papillomavirus-16 positive cervical cancer cells. Journal of Biomolecular Structure and Dynamics. 2025;:1. doi: 10.1080/07391102.2025.2497459
  24. Zilani M, Islam MM, Biswas P, Bibi S, Albadrani GM, Al‐Ghadi MQ, et al. Discovery of Potential Anti‐Alzheimer Compounds from Dioscorea hamiltonii: An Integrated In Vivo and In Silico Approach. ChemistrySelect. 2025;10(29). doi: 10.1002/slct.202501516
  25. Alghamdi S, Baeissa HM, Kamal MA, Rafeeq MM, Zahrani AA, Maslum AA, et al. Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. 2024;42(16):8268. doi: 10.1080/07391102.2023.2248260
  26. Alshehri MA, Asiri SA, Alzahrani A, Alazragi RS, Alqahtani LS, Alqosaibi AI, et al. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study. Medical Oncology. 2023;40(11). doi: 10.1007/s12032-023-02203-6
  27. Kamal MA, Akhtar S. Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs. Current Medicinal Chemistry. 2024;31(5):552. doi: 10.2174/092986733105230911112507
  28. Srivastava S, Haneef M, Saxena VL, Khan M, Khan S. Structure and Ligand-based In Silico Studies towards the Natural Inhibitors against Receptor Recognition Spike Protein of SARS-CoV-2. The Open Bioinformatics Journal. 2024;17(1). doi: 10.2174/0118750362284177240304055831
  29. Alsaiari AA, Almufarriji FM, Hazazi A, Almarghalani DA, Bakhuraysah MM, Alrehaili AA, et al. Multitargeted docking approach reveals droxidopa against DNA replication and repair-related protein of cervical cancer. Scientific Reports. 2024;14(1). doi: 10.1038/s41598-024-72770-9
  30. Shah AA, Khan M, Akhtar S. Design and Modeling of 4-Anilinoquinazoline Derivatives as Small Molecule Inhibitors of T790M/C797S EGFR Mutations to Abandon the Phenomenon of Tumor Angiogenesis. The Open Bioinformatics Journal. 2023;16(1). doi: 10.2174/18750362-v16-e230724-2023-6
  31. Khan F, Shah AA, Kumar A, Akhtar S. In Silico Investigation against Inhibitors of Alpha-Amylase Using Structure-based Screening, Molecular Docking, and Molecular Simulations Studies. Cell Biochemistry and Biophysics. 2024;82(3):2873. doi: 10.1007/s12013-024-01403-9
  32. Alsaiari AA, Gharib AF, Bakhuraysah MM, Alrehaili AA, Algethami SM, Alsaif HA, et al. Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach. Medical Oncology. 2024;41(5). doi: 10.1007/s12032-024-02366-w
  33. Almasoudi HH, Mashraqi MM, Alshamrani SA, Alharthi AA, Alsalmi O, Nahari MH, et al. Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor. Pharmaceuticals. 2024;17(2):208. doi: 10.3390/ph17020208
  34. Almasabi S, Almasoudi HH, Albargy H, Alabbas M, Al-Mansour F. Alternative use of droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies. Medical Oncology. 2025;42(5). doi: 10.1007/s12032-025-02700-w
  35. Ahmad S, Singh AP, Bano N, Raza K, Singh J, Medigeshi GR, et al. Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis. International Journal of Biological Macromolecules. 2024;270:132332. doi: 10.1016/j.ijbiomac.2024.132332
  36. Hakeem IJ, Alahdal H, Baeissa HM, Bakhsh T, Rafeeq M, Habib AH, et al. Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer’s Disease. Pharmaceuticals. 2025;18(6):772. doi: 10.3390/ph18060772
  37. He Z, Chen Y, Yang S, Chen C, He Y, Liu S. MFAP2 promotes metastasis and drug resistance by regulating epithelial-to-mesenchymal transition through EGFR signaling pathway in colorectal cancer cells. Genes & Diseases. 2025;:101800. doi: 10.1016/j.gendis.2025.101800
  38. Xiao H, Gui Y, Li X, Dai W, Feng C, Li G, et al. Explore on screening COX-2 inhibitors from the essential oil of Solanum lyratum Thunb. By molecular docking and molecular dynamics simulation. Heliyon. 2024;10(18):e37652. doi: 10.1016/j.heliyon.2024.e37652
  39. Alghamdi YS, Mashraqi MM, Alsalmi O, Alharthi AA, Gharib AF. Evaluating the polypharmacological potency of indenopyrazole against lung cancer oxidoreductase, chaperone, transferase, and hydrolase proteins. Medical Oncology. 2025;42(6). doi: 10.1007/s12032-025-02723-3
  40. Ahmad S, Bano N, Raza K. Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins. International Journal of Biological Macromolecules. 2025;306:141703. doi: 10.1016/j.ijbiomac.2025.141703

Dimensions

Article Metrics

Metrics Loading ...

PlumX